Raymond James Financial’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
357,205
-93,453
-21% -$586K ﹤0.01% 3452
2026
Q1
$2.73M Buy
450,658
+26,030
+6% +$152K ﹤0.01% 3100
2025
Q4
$3.04M Buy
424,628
+33,516
+9% +$238K ﹤0.01% 2919
2025
Q3
$2.95M Buy
391,112
+92,823
+31% +$678K ﹤0.01% 2875
2025
Q2
$1.86M Buy
298,289
+276,644
+1,278% +$1.28M ﹤0.01% 3133
2025
Q1
$67.5K Buy
21,645
+326
+2% +$1.14K ﹤0.01% 4608
2024
Q4
$84.2K Buy
+21,319
New +$74.8K ﹤0.01% 4549

Other funds holding EVLV

Raymond James Financial's EVLV Position: Q2 2026 in Review

Raymond James Financial reduced its Evolv Technologies (EVLV) stake by 21% in Q2 2026, selling an estimated $586K and leaving 357,205 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

Raymond James Financial first reported a position in EVLV in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.04M in Q4 2025. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Raymond James Financial held 357,205 shares of Evolv Technologies worth $2.07M as of Q2 2026.
  • Raymond James Financial sold 93,453 Evolv Technologies shares in Q2 2026, an estimated $586K.
  • Evolv Technologies made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3452 holding.
  • Raymond James Financial first reported a position in Evolv Technologies in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Evolv Technologies position peaked at $3.04M in Q4 2025.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.